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Abstract
Objective: To evaluate the effectiveness of individually tailored cognitive behavioral therapy (CBT) for reducing depressive symptoms with or
without anxiety poststroke.
Design: Multicenter, assessor-blinded, randomized controlled trial.
Setting: Ambulatory rehabilitation setting.
Participants: Patients who had a Hospital Anxiety and Depression Scale-depression subscale (HADS-D) score >7 at least 3 months poststroke
(NZ61).
Interventions: Participants were randomly allocated to either augmented CBT or computerized cognitive training (CCT). The CBT intervention
was based on the principles of recognizing, registering, and altering negative thoughts and cognitions. CBT was augmented with goal-directed
real-life activity training given by an occupational or movement therapist.
Main Outcome Measures: HADS-D was the primary outcome, and measures of participation and quality of life were secondary outcomes.
Outcome measurements were performed at baseline, immediately posttreatment, and at 4- and 8-month follow-up. Analysis was performed with
linear mixed models using group (CBT vs CCT) as the between-subjects factor and time (4 assessments) as the within-subjects factor.
Results: Mixed model analyses showed a significant and persistent time effect for HADS-D (mean difference, 4.6; 95% confidence interval,
5.7 to 3.6; P<.001) and for participation and quality of life in both groups. There was no significant group  time effect for any of the outcome
measures.
Conclusions: Our augmented CBT intervention was not superior to CCT for the treatment of mood disorders after stroke. Future studies should
determine whether both interventions are better than natural history.
Archives of Physical Medicine and Rehabilitation 2017;98:687-94
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http://dx.doi.org/10.1016/j.apmr.2016.10.013adequate treatment of poststroke depressive symptoms is of the
utmost importance. Typically, studies on the treatment of
depressive symptoms after stroke have focused on pharmacologic
interventions. However, drug treatment only produces small
improvements in mood, and it is associated with a frequent
occurrence of side effects,3,4 restricting routine prescription.
Because poststroke depressive symptoms are strongly associated
with individuals’ perception of, and coping with the consequenceshabilitation Medicine
688 J.A. Kootker et alof, stroke,5 a psychological treatment approach seems warranted.
Because cognitive behavioral therapy (CBT) is aimed at changing
irrational cognitions and negative thoughts, its effects may endure
after treatment, and chances of relapse of symptoms may be
smaller compared with pharmacotherapy.6-8 In addition, the side-
effect profile of psychological treatment is favorable compared
with medication.6 However, psychological treatments of post-
stroke mood disorders have not yet yielded convincing results.9,10
To our knowledge, only 1 randomized controlled trial has been
reported investigating psychological treatment of poststroke
depressive symptoms.10 This study yielded inconclusive results
regarding the effectiveness of CBT. As the authors acknowledged,
this work was a pioneering study with several methodologic
weaknesses that compromised its quality. For instance, cognitive
impairments were not considered in the inclusion criteria, and the
therapy content was insufficiently adjusted to the cognitive con-
sequences of stroke. In addition, the training of therapists was
limited. Other researchers argued that to optimize the effective-
ness of CBT in patients with stroke, cognitive and emotional
impairments and limited awareness of deficits should be taken into
account.8 It was also recommended that CBT should be
augmented with real-life activity training to help patients and their
caregivers set and attain realistic goals aimed at social participa-
tion, taking into account their motor and cognitive impairments.8
In addition, anxiety symptoms should be recognized and
addressed in CBT treatment because these are often associated
with depressive symptoms after stroke.11,12
In a pilot study, we already assessed the feasibility of a CBT
intervention aimed at reducing depressive symptoms in stroke
survivors.13 Three of 5 participants showed positive results on
mood and quality of life immediately after treatment, and these
positive results were retained at 3-month follow-up. These find-
ings justified the conduct of a multicenter randomized controlled
trial as part of the Restore4Stroke study in The Netherlands.14,15
In the present study, we hypothesized that patients treated with
individually tailored augmented CBT would show a larger
decrease in depressive symptoms and more improvement in social
participation and quality of life than those receiving computerized
cognitive training (CCT). CCT was selected as the comparator
intervention to control for Hawthorne effects, in the expectation
that CCT might improve cognition but not mood.Methods
Participants
Participants were recruited over a period of 18 months from
January 2012. They were screened for eligibility by their treating
physicians and psychologists during regular outpatient visits in the
following 7 participating rehabilitation centers or hospital reha-
bilitation departments in The Netherlands: Groot Klimmendaal,
Arnhem; St Maartenskliniek, Nijmegen; Adelante, Hoensbroek;
Roessingh, Enschede; VieCuri, Venlo; Tolbrug, ’s Hertogenbosch;List of abbreviations:
CBT Cognitive behavioral therapy
CCT Computerized cognitive training
CI Confidence interval
HADS-D Hospital Anxiety and Depression
Scale-depression subscaleand ViaReva, Apeldoorn. Participants were eligible when they met
the following inclusion criteria: they should (1) have sustained any
type of clinically confirmed stroke at least 3 months earlier; (2) a
score >7 on the Hospital Anxiety and Depression Scale-
depression subscale (HADS-D)16,17; (3) be 18 years; (4) have
only mild cognitive impairments (Mini-Mental State Examination
score18 >27 out of 30) and score positively on the
communication-related items of the National Institutes of Health
Stroke Scale19; and (5) master the Dutch language. Exclusion
criteria were (1) prestroke major depression requiring psychiatric
care, (2) premorbid disability as reflected in a Barthel Index score
<19 (out of 20),20 (3) stay in an inpatient setting, (4) severe co-
morbidity that might affect mood (eg, cancer), and (5) poststroke
major depression requiring a start with medication.
The study design and methods were previously published16 and
approved by the Medical Ethical Committee of Nijmegen (The
Netherlands) and by the executive boards of all participating
rehabilitation institutes. The adjusted time points of assessment
were approved post hoc by the same medical ethical committee.
Procedure
After referral to the primary investigator (J.A.K.), participants
were enrolled based on the inclusion and exclusion criteria. Oral
and written informed consent was obtained by the primary
investigator (J.A.K.). Subsequently, patients were randomized to
either 4 months of augmented CBT or an equal period of CCT.
Interventions were given in the same 6 rehabilitation institutions
where patients were treated.
All outcome measures were collected at 4 time points. Initially,
we intended to measure at baseline, immediately posttreatment,
and 6 and 12 months posttreatment.15 Because of a lower than
expected inclusion rate, the timing of the assessments was
adjusted to baseline (t0), immediately posttreatment (t1), and 4
(t2) and 8 months (t3) posttreatment (fig 1). All assessments took
place in the rehabilitation institute where the patient was treated.
Baseline assessments were performed by the primary investigator
(J.A.K.). From t1, all outcome assessments were performed by
research assistants who were not involved in the administration of
the interventions and who were blinded to treatment allocation of
the participants. When patients mentioned the content of their
intervention to the assessor, this was reported, and the subsequent
assessment was performed by a different, still blinded, assessor.
Randomization
Stratified block randomization (block size 4) was performed by a
randomization program for each participating rehabilitation
institution separately. Main factors that were expected to affect
outcomes were selected for minimization (ie, rehabilitation insti-
tute, patients’ anxiety level [Hospital Anxiety and Depression
Scale-anxiety subscale score 7 vs >7]). As a result, for each
participating institute, patients with high anxiety scores and those
with low anxiety scores were equally allocated to either the
experimental or nonexperimental group.
Interventions
Both interventions were administered during a 4-month time
period, with a minimum of 13 and a maximum of 16 sessions.
Each session consisted of two 20- to 25-minute blocks divided by
a 10- to 15-minute break. Therefore, each session lastedwww.archives-pmr.org
Fig 1 Flowchart of the Restore4Stroke Trial for depressive symptoms after stroke (Consolidated Standards of Reporting Trials diagram). t0,
baseline; t1, immediately posttreatment; t2, 4 months posttreatment; t3, 8 months posttreatment.
Cognitive behavioral therapy for poststroke depressive symptoms 689approximately 1 hour. The CBT intervention was administered by
a certified health care psychologist (therapist) who had ample
experience in treating depression and stroke rehabilitation in
general. All therapists were additionally trained by the primary
investigator (J.A.K.) to master the specific aspects of the current
CBT intervention. Goals for attaining daily life activities were
primarily set together by the patient and the therapist using pic-
tures from the Activity Card Sort.21 Concurrently with the psy-
chological sessions, the CBT intervention was augmented with 3
sessions of occupational therapy or movement therapy. During
these sessions, an occupational or movement therapist helped
patients with establishing and attaining goals aimed at meaningful
activities and social participation. These goals were attuned to the
content of the psychological sessions. In the case of a baseline
Hospital Anxiety and Depression Scale-anxiety subscale score
>7, the protocol was extended with an additional (fourth) occu-
pational therapy/movement therapy session aimed at relaxation
techniques, as provided by the Dutch Heart Foundation.22 To
implement the recommendations made by Broomfield et al,10
therapists were continuously reminded to use concrete, repeti-
tive, accessible, slow, and structured communication strategies, as
proposed by Judd.23 A detailed description of the applied CBT
intervention has been published elsewhere.14
We selected CCT as the comparative intervention to control for
nonspecific (eg, Hawthorne) effects. In a previous study, this type
of training yielded high satisfaction scores.24 In the current study,
CCTwas largely self-administered, but either cognitive trainers or
psychological assistants were present to assist the participants
during the training. They were instructed not to engage in any
conversation with the patients about topics other than the cogni-
tive training. A desktop was setup with headphones and a
keyboard with colored patches attached to 2 keys. Patients could
select any (or a combination) of 4 specific cognitive domains for
training (ie, attention, memory, executive functioning, visual
attention). As patients improved, the Cogniplusa program adjusted
the level of difficulty for each training task accordingly. In this
way, each patient trained at his/her individual level and pace.www.archives-pmr.orgCointerventions
During the study, patientswere requested tominimize cointerventions
by other therapists and to refrain from starting new medication.
Any existing (psycho)pharmacologic treatment was continued. All
cointerventions were registered in a booklet at each assessment.
Assessments
Baseline assessments consisted of the following characteristics: age
(years), sex (male or female), employment (yes or no), time since
stroke (months), stroke type (ischemic, hemorrhagic, or other),
affected hemisphere (left, right, or other), mobility (Stroke Impact
Scale mobility subscale25), comorbidity (Cumulative Illness Rating
Scale26), level of independence (Barthel Index20), and cognition
(Mini-Mental State Examination18). Except for comorbidity, higher
scores reflect better outcomes on the scales mentioned.
The primary outcome was the severity of depressive symptoms
as assessed with the HADS-D. The Hospital Anxiety and
Depression Scale has been specifically validated to assess
depressive symptoms in patients with stroke.17 Secondary out-
comes were the Hospital Anxiety and Depression Scale-anxiety
subscale for symptoms of anxiety, the Post Stroke Depression
Rating Scale for assessing the more qualitative aspects of mood,27
coping assessed with the Utrecht Proactive Coping Competence
scale,28 quality of life assessed with the Stroke Specific Quality of
Life scale,29 social participation assessed with the Utrecht Scale
for Evaluation of Rehabilitation-Participation,30 and subjective
well-being assessed with a life satisfaction questionnaire (Life
Satisfaction questions).31 Except for the Hospital Anxiety and
Depression Scale and Post Stroke Depression Rating Scale scores,
higher scores reflect better outcomes.
Statistical analyses
This study was originally powered on the HADS-D at 4 months
posttreatment (ie, t2), without accounting for improved precision
Table 1 Patient characteristics at baseline
Characteristic
CBT Patients CCT Patients
n
Median (range)
or n (%) n
Median (range)
or n (%)
Age (y) 31 61 (45e79) 30 61 (25e76)
TSS (mo) 26 (2e243) 21.5 (2e138)
Men 31 19 (61.3) 30 19 (63.3)
Employed 31 9 (29) 30 13 (43.3)
Stroke type 28 28
Infarct 21 (75) 24 (85.7)
Hemorrhage/other 7 (25) 2 (7.1)
Unknown 0 2 (7.1)
Stroke hemisphere 26 28
Left 15 (57.7) 9 (32.1)
Right 8 (30.8) 11 (39.3)
Other 3 (11.5) 8 (28.6)
SIS mobility 31 65 (13e98) 30 65 (25e100)
CIRS 31 3 (0e18) 30 5 (0e13)
Barthel Index 31 20 (17e20) 30 20 (12e20)
MMSE 31 30 (27e30) 30 30 (24e30)
HADS 31 30
Depression 12 (8e20) 12 (8e20)
Anxiety 9 (4e17) 10 (1e18)
Abbreviations: CIRS, Cumulative Illness Rating Scale (range, 0e52);
HADS, Hospital Anxiety and Depression Scale (subscale range, 0e21);
MMSE, Mini-Mental State Examination (range, 0e30); SIS, Stroke
Impact Scale (range, 10e50); TSS, time since stroke.
690 J.A. Kootker et albecause of repeated measures (at t1 and t3). To obtain a power of
80% with an a level of 5%, we originally aimed to include a total
of 106 participants.13 In this calculation, adjustments for baseline
values (ie, t0) and posttreatment values (ie, at t2) and a dropout
rate of 15% were taken into account. Because of the lower than
expected inclusion rate, we investigated whether accounting for
the additionally repeated measures at t1 and/or t3 could provide
sufficient power. Using the method described by de Hoop,32 we
calculated that including an extra posttreatment value (ie, t1)
would provide sufficient power with half the originally planned
subjects. This was discussed with and approved by the medical-
ethical committee. As a consequence, a minimal number of 53
participants was needed.
Median and ranges or numbers and percentages were used for
descriptive statistics in the case of continuous and categorical
variables, respectively. After confirming normative distribution of
the dependent continuous variables, we used linear mixed models
for repeated measures to study the differences between groups for
each outcome (dependent variable). The independent fixed vari-
ables were group (CBT vs CCT), baseline score, time point of
measurement (t0et3), the minimization factor Hospital Anxiety
and Depression Scale-anxiety subscale score >7, and the inter-
action term between point of measurement and group. The
participating institute was treated as a random variable. We pre-
sent the baseline-adjusted mean differences between groups at
each time point with 95% confidence intervals (CIs). The effects
of the intervention on the primary and secondary outcome mea-
sures were analyzed according to the intention-to-treat principle
using SAS 9.2 for Windowsb and IBM SPSS Statistics 20 for
Windows.c Data analysis was performed by an independent stat-
istician who was blinded to group allocation.Results
Participants
Figure 1 presents the patient flow throughout the study. Trial
inclusion took place from January 2011 until August 2012, and
ended according to prior agreements with the medical ethical
committee. Out of 163 referred patients, 61 ultimately partici-
pated. Of these, 31 patients were assigned to the CBT intervention
and 30 patients were assigned to the CCT intervention. Incomplete
interventions occurred once in the CBT group (change in protocol
by psychologist) and 4 times in the CCT group (related to suicidal
thoughts: nZ1; dissatisfaction with intervention: nZ2; no
reason/not specified: nZ1). Fifty-two patients completed the
posttreatment assessment, of whom 44 completed the last
follow-up. Patient characteristics are listed in table 1.Control of bias
More than 95% of all assessments were performed according to
the protocol.15 Some exceptions were as follows: extra pauses (t0,
nZ1), missing page in assessment booklet (t1, nZ1), Utrecht
Proactive Coping Competence Scale questionnaire too difficult to
understand (t1, nZ1), and Utrecht Proactive Coping Competence
Scale questionnaire and Life Satisfaction questions filled in at
home because of time constraints (t1, nZ1). Assessor unblinding
by the patient occurred in 13% of the t1 assessments, 10% of the
t2 assessments, and 9% of the t3 assessments. In the CBT group, 1patient had sought contact with a psychologist outside the trial for
additional anxiety therapy (t1) and 1 patient had started antide-
pressants (t2). In the CCT group, 1 patient commenced with
antidepressants at t1.
Interaction effects and group differences
Table 2 presents the primary and secondary outcomes by point of
measurement for each group. Changes in the HADS-D were never
significant between groups (fig 2). No group differences after
treatment were found for any of the primary or secondary
outcomes. Therefore, a parallel line model is presented for all
variables in table 3.
Time effects
Table 3 depicts the estimated mean differences between points of
measurement, adjusted for baseline values, for all outcomes, and
for both groups together. A posttreatment effect was found for the
primary outcome, HADS-D (mean difference, 4.6; 95% CI,
5.7 to 3.6). The overall time effect of the HADS-D from
posttreatment to 8-month follow-up was not significant. However,
the HADS-D showed a significant increase from posttreatment to
4-month follow-up (mean difference, 1.1; 95% CI, 0.2e1.9),
followed by a significant decline from 4-month to 8-month
follow-up (mean difference, 1.4; 95% CI, 2.1 to 0.7) for
both groups.
A posttreatment effect was also observed for the Hospital
Anxiety and Depression Scale-anxiety subscale (mean difference,
2.6; 95% CI, 3.6 to 1.5), Post Stroke Depression Rating
Scale (mean difference, 3.4; 95% CI, 4.9 to 2.0), Utrechtwww.archives-pmr.org
Table 2 Observed median (range) of the primary and secondary outcomes by point of measurement by CBT and CCT groups
Outcome
Baseline Posttreatment 4-mo Follow-Up 8-mo Follow-Up
n Median (range) n Median (range) n Median (range) n Median (range)
HADS-D
CBT 31 12.0 (8.0e20.0) 24 8.00 (0.0e15.0) 24 9.0 (0.0e19.0) 23 8.0 (0.0e19.0)
CCT 30 12.0 (8.0e20.0) 28 9.00 (1.0e14.0) 24 8.5 (0.0e16.0) 20 7.5 (0.0e12.0)
HADS-A
CBT 31 9.0 (4.0e17.0) 24 6.5 (2.0e18.0) 24 6.0 (0.0e17.0) 23 5.0 (0.0e17.0)
CCT 30 10.0 (1.0e18.0) 28 7.5 (0.0e16) 24 7.0 (2.0e15.0) 20 6.0 (0.0e13.0)
PSDRS
CBT 30 14.0 (3.0e24.0) 23 10.3 (2.0e21.0) 24 8.0 (2.0e22.3) 22 8.2 (1.0e18.0)
CCT 30 12.0 (4.0e25.3) 28 9.0 (1.0e21.0) 24 8.5 (0.0e23.3) 20 7.5 (2.0e18.0)
UPCC
CBT 31 2.5 (1.5e3.2) 24 2.5 (1.4e3.8) 23 2.6 (1.7e3.5) 23 2.5 (1.7e3.6)
CCT 30 2.5 (1.5e3.8) 27 2.4 (1.7e4.0) 23 2.4 (1.5e3.8) 20 2.7 (1.8e4.0)
SSQoL
CBT 31 3.2 (2.1e4.7) 24 3.8 (2.2e5.0) 24 3.5 (2.1e4.9) 24 3.7 (2.2e5.0)
CCT 30 3.1 (2.0e4.7) 28 3.5 (1.9e4.8) 24 3.3 (2.2e4.7) 20 3.7 (1.8e5.0)
USERP vocational activities
CBT 31 12.6 (5.0e30.0) 24 14.0 (5.0e35.0) 24 11.5 (5.0e25.0) 24 12.7 (5.0e30.0)
CCT 30 14.5 (5.0e50.0) 28 13.4 (5.0e45.0) 24 13.1 (0.0e35.0) 20 14.3 (0.0e45.0)
USERP leisure activities
CBT 31 45.0 (7.5e82.5) 24 43.8 (20.0e77.5) 24 51.3 (27.5e70.0) 24 47.5 (17.5e77.5)
CCT 30 42.5 (15.0e80.0) 28 45.0 (5.0e70.0) 24 46.3 (12.5e72.5) 20 50.0 (17.5e70.0)
USERP satisfaction
CBT 31 56.3 (19.4e88.9) 24 66.3 (27.8e94.4) 24 68.1 (30.6e99.4) 24 63.9 (30.6e91.7)
CCT 31 51.4 (11.1e78.1) 28 62.5 (30.6e88.9) 24 62.5 (30.6e80.6) 20 63.9 (34.4e91.7)
USERP restriction
CBT 31 72.5 (50.0e94.4) 24 75.0 (43.6e100.0) 24 77.6 (55.0e94.4) 24 73.8 (52.8e100.0)
CCT 30 71.4 (46.9e100.0) 28 75.0 (50.0e94.4) 24 73.8 (50.0e96.9) 20 81.2 (52.8e100.0)
LS2
CBT 31 4.0 (2.0e11.0) 24 6.0 (3.0e13.0) 24 7.5 (2.0e13.0) 24 7.0 (0.0e13.0)
CCT 30 4.0 (2.0e12.0) 28 5.0 (3.0e11.0) 24 6.5 (2.0e13.0) 20 7.0 (3.0e13.0)
NOTE. Ranges are as follows: HADS-A (0e21); HADS-D (0e21); LS2 (2e13); PSDRS (0e45); SSQoL (1e5); UPCC (1e4); USERP (0e100, each subscale).
Abbreviations: HADS-A, Hospital Anxiety and Depression Scale-anxiety subscale; HADS-D, Hospital Anxiety and Depression Scale-depression subscale;
LS2, 2 Life Satisfaction questions; PSDRS, Post Stroke Depression Rating Scale; SSQoL, short Stroke Specific Quality of Life Scale; UPCC, Utrecht
Proactive Coping Competence list; USERP, Utrecht Scale of Rehabilitation-Participation.
Cognitive behavioral therapy for poststroke depressive symptoms 691Scale for Evaluation of Rehabilitation-Participation satisfaction
subscale (mean difference, 9.7; 95% CI, 5.4e14.1), Stroke
Specific Quality of Life Scale (mean difference, 0.3; 95% CI,
0.1e0.5), and Life Satisfaction questions (mean difference, 1.3;Fig 2 Mean scores for CCT and CBT patient groups at all assessment
time points.
www.archives-pmr.org95% CI, 0.7e2.0), but not for the Utrecht Proactive Coping
Competence Scale. However, the Utrecht Proactive Coping
Competence Scale showed a significant change from posttreatment
to 8-month follow-up (mean difference, 0.1; 95% CI, 0.0e0.3), as
did the Post Stroke Depression Rating Scale (mean difference,
1.9; 95% CI, 3.1 to 0.7) and Life Satisfaction questions
(mean difference, 0.6; 95% CI, 0.0e1.3).Discussion
The aim of our study was to evaluate the effectiveness of indi-
vidually tailored CBT for reducing depressive symptoms with or
without anxiety after stroke. The results of our multicenter ran-
domized controlled trial indicate that there was significant and
persistent improvement of depressive and anxiety complaints after
treatment; however, this was independent of the type of interven-
tion. In addition, the subjective ratings of patients’ participation
level (Utrecht Scale for Evaluation of Rehabilitation-Participation
satisfaction subscale) increased after treatment, as did quality of



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































692 J.A. Kootker et alThese results appear to be similar to those of Lincoln and
Flannaghan,10 even though our CBT was of longer duration and
higher intensity, was augmented with occupational or movement
therapy, was provided by well-trained psychologists, and took
cognitive impairments and anxiety complaints into account. Like
our study, Lincoln and Flannaghan10 found no differences between
intervention groups (ie, no intervention, attention placebo,
CBT)33; however, they did find a small decline (3e4 points) in
median score on the Beck Depression Inventory (range, 0e63) for
each group immediately after the intervention period. Notably, the
relative improvements that were observed in the present study
were larger (ie, 3e4 points on the HADS-D; range, 0e21), which
suggests that both treatments may have caused a beneficial effect.
As our study lacked a nonintervention group, it cannot be ruled
out that any beneficial effect of either CBT or CCT was nonspe-
cific or that HADS-D scores simply improved because of regres-
sion to the mean. However, the observed improvements were
relatively large, whereas recent literature shows that depressive
symptoms poststroke (measured with the Beck Depression In-
ventory) remain stable over the first 2 years.34 In addition, our
Restore4Stroke consortium recently reported nonsignificant fluc-
tuations in poststroke depressive symptoms (maximally 2-point
change in HADS-D) over the first 2 years.35 These findings point
toward the possibility that the observed decline in depressive
symptoms after treatment in the present study may actually
represent a beneficial effect of both CBT and CCT. This notion
raises the question of what the effective component of CCT might
have been because we took care that cognitive trainers and psy-
chological assistants were instructed not to address issues other
than the cognitive training. Interestingly, in a recent evaluation of
CCT, Akerlund et al36 showed that patients with acquired brain
injury who suffered from depressive complaints demonstrated
mood improvements after CCT, which suggests that cognitive
training may improve mood through motivational mechanisms or
perhaps through cognitive improvement. Irrespective of the
underlying mechanism, it may be that such effects occurred in our
study. Unfortunately, at the initiation of our study, beneficial effect
results of CCT on mood problems were not yet known.
Quality of life scores and satisfaction with life and with
participation equally and persistently improved in both groups
after treatment, as did anxiety level. Proactive coping did not
immediately respond after the intervention, but it improved during
follow-up, together with life satisfaction and qualitative aspects of
mood. In a recent study from our Restore4Stroke consortium,37
change in depression scores was associated with subjective
experience of participation, emphasizing that rehabilitation should
focus on resuming occupational activities when treating depres-
sive complaints after stroke. Although in the present study this
approach was applied in the CBT intervention, it remains to be
explained why we found no group differences for any of the
secondary outcomes, and why CBT and CCT had similar effects.
Study limitations
Apart from the absence of a nonintervention group, the main
limitation of this study is the relatively small patient sample and
the recruitment through rehabilitation institutes, which limits the
generalizability of our results. It is well known that recruiting
patients with depressive symptoms for participation in research is
notoriously difficult.38 Patients who did participate may have been
more motivated than those who did not, which may have led to
selection bias. This too would limit the generalizability of ourwww.archives-pmr.org
Cognitive behavioral therapy for poststroke depressive symptoms 693results. Although we did not reach the inclusion number as orig-
inally planned, the risk of false-negative outcomes for group by
time interactions seems to be small because no trends were
observed toward significant interactions. We were not able to
directly compare our results with those of Lincoln and Flanna-
ghan10 because we used the HADS-D instead of the Beck
Depression Inventory as a primary outcome. This choice was
determined by the intention to prevent overestimation of depres-
sive symptoms because of general symptoms (eg, fatigue) of
stroke. Unlike the Beck Depression Inventory, the Hospital
Anxiety and Depression Scale does not include fatigue as a
symptom of depressed mood.Conclusions
This randomized controlled trial showed persistent improvement
of depressive symptoms, anxiety symptoms, quality of life,
satisfaction with life, and participation after both CBT and CCT in
patients with depressive complaints minimally 3 months after
stroke. This finding implies that, for now, both types of
interventions may be considered to improve depressive symptoms
after stroke. Future research should determine whether both
interventions are better than natural history and what underlying
mechanisms are responsible for such effects.Suppliers
a. Cogniplus; SCHUHFRIED.
b. SAS 9.2; SAS Institute.
c. IBM SPSS Statistics 20; IBM.Keywords
Anxiety; Depression; Psychology; Rehabilitation; Stroke
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